Bionomics initiaties trial of anxiety drug in France
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Feb, 2015
Singapore: Australia-based Bionomics has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the drug c...Read more
Hatchtech gets $6 mn for head lice R&D
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2012
Singapore: Specialty pharmaceutical company Hatchtech has completed a $6 million financing led by OneVentures Innovatio...Read more
Australian sandalwood maker buys two US pharma firms
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Jun, 2015
Singapore: West Australian sandalwood producer TFS Corporation has announced the acquisition of two US pharma firms in a...Read more
Saluda Medical secures $5 mn from NSW Govt
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: NICTA start-up company Saluda Medical has been awarded $5 million by the New South Wales Government to suppor...Read more
Invion completes patient enrolment for asthma drug trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2015
Singapore: Australian drug development company, Invion, has completed the enrolment in its phase II clinical trial of IN...Read more
CPR ventures into large molecule analytics
Australia | News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2013
Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide...Read more
BioDiem, US NIAID advance TB research
Australia | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has detailed a new phase of res...Read more
India, Australia to collaborate on science and research
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2014
Singapore: There must have been many Indian prime ministers who have visited Australia before. But this one by the curre...Read more
Gene therapy for leukemia, blood cancer patients
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2013
Singapore: Over six research groups have treated more than 120 patients with many different types of blood and bone-marr...Read more
Monash-GSK partnership wins collaboration award
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Nov, 2013
Singapore: Monash Institute of Pharmaceutical Sciences (MIPS) has been recognised for the Monash-GSK Australian Centre f...Read more
GSK eyes emerging markets with $27 mn investment
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Nov, 2014
Singapore: Recently GlaxoSmithKline has announced introduction of a new technology to its Boronia manufacturing site in ...Read more
Breast cancer market to reach $17.2 bn by 2021'
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2016
Singapore: Global breast cancer therapeutics market is set to increase in value from $10.4 billion in 2014 to $17.2 bill...Read more
Minomic, US firm to develop prostrate cancer drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2014
Singapore: Australian biotechnology company Minomic International has collaborated with US partner to develop a potentia...Read more
Brandon Capital raises $200 mn for lifesciences funding
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Apr, 2015
Singapore: Brandon Capital Partners has raised Australia's largest ever venture capital fund for the lifesciences indust...Read more
Australian CRO Novotech opens new office in India
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2015
Singapore: Further expanding its presence in Asia, Australia's leading Contract Research Organization Novotech recently ...Read more
Pharmaxis, Synairgen to develop drugs for fatal lung disease
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Aug, 2015
Singapore: Australian pharmaceutical company Pharmaxis, and UK biotechnology company, Synairgen, have entered into a res...Read more
Phylogica inks a deal with Genentech
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Dec, 2014
Singapore: Australia-based drug discovering company, Phylogica has inked a pact with US-based Genentech, to discover nov...Read more
Singapore stem cell firm initiates for ASX listing
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2015
Singapore: On Q Group, changing its name to StemCell United, a Singapore-based biotechnology company headquartered in Au...Read more